reference/34178027

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34178027

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	1043
issn	1875-8908 1387-2877
issueIdentifier	3
pageRange	1035-1043
publicationName	Journal of Alzheimer's disease : JAD
startingPage	1035
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e423e98d115894f5b30465dcb1113e0c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e01b2377fafe8e7c7349c9fbe5f031a9
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_562f37378ff3c5be793443d27ebe42e0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_542db50b465f6f932f3381877175e789 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f567aa17dcf88f3df6d0cceb7191c852 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8ab4e3c7091d1cd6447f093dcb1630c1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_24c4d664b954be5fdb87c66af0c5ee62 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9883da64c4440435e166e0084e73567d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f45f5ba4b1b2a55ef4e433e286d2ac74 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7074d28a3e797fd75448828a57fdffc7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f5495c41498d8d805b851eb0e2117110 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_65d3516c478f3059e99ba927d37a9d14 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d35cf9b09b2481f17c567ce387d9be7e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c8690df009664e4aab4b6e98c66b50c9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6b9453892c2156fdfea081fcaab54fe9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8bdefdef31655ce5ad79988aeb916221 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8c9e9652d1138fed152257774c68104e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9dc6dd9a5dec9576b201c5bd03749d38 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c55ff3b2394ed57c016ea6376cdd61c8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_279072a8da59280a41224db934623c83 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bb2f8c8f50044601ed2e7cd08df822d4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7852d84f6584e4d4608722b3fd6b4a70 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4f977c1f4be0d05c61ae47859066f18e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8f3dc186c628cf916ce371fad06c7e2f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_941add445f8f1162d1eaa758eb88e6b1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d47f05ae5bf9fa3caffe2690475b5eb2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7855a37df1958975a766765361cd0326 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_71ca1dd1d301363883e7da16bb64615c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e34a239051b4e71f125ef5472116cc1a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6b60491b3bc139eb323f4cb8230d332b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7004dbd6ea24edafd776f8bc472f49ce http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8ae31fa81c7cd338fbc61c80cf94de9f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_eff0f66a56c9f9a2c6cd954cbcbc2c31 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ec84b452a9a8c96b50f99917f5df6603 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5f7e7ee51ca0b71b47a44a0cddb25340 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_40c0c19df463a96c7b46f412f50bd432
bibliographicCitation	Mozersky J, Roberts JS, Rumbaugh M, Chhatwal J, Wijsman E, Galasko D, Blacker D; AGREED. Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants. J Alzheimers Dis. 2022;90(3):1035–43. PMID: 35404285; PMCID: PMC9794032.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_204d90d81ae7beca2bf993d18469ad5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb9965f5de516c6206adadc9f7a1a0cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17bfc7e3648d0dd53cf5988448982038 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb2e8c016e13047de4c657d84d27021c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_492200b128898a7586ec3e771a978d6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e96d5f45803a78f32407801ade41e19b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e63dffe5cc5f35c3a9b4e4dfdaad76b8
date	2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9794032 https://pubmed.ncbi.nlm.nih.gov/35404285 https://doi.org/10.3233/jad-220113
isPartOf	https://portal.issn.org/resource/ISSN/1875-8908 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1387-2877
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Spillover: The Approval of New Medications for Alzheimer’s Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants
discusses	http://id.nlm.nih.gov/mesh/M0455693 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0001047
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000686 http://id.nlm.nih.gov/mesh/D000544Q000523 http://id.nlm.nih.gov/mesh/D060825Q000523 http://id.nlm.nih.gov/mesh/D003704
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015415 http://id.nlm.nih.gov/mesh/D000682 http://id.nlm.nih.gov/mesh/D058227 http://id.nlm.nih.gov/mesh/D030881
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Total number of triples: 82.